SCHEMBL30228063

SCHEMBL30228063

O=Cc1ccc2c(-c3ccc(F)cc3Cl)cc(=O)oc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 6/20 0.46
▸ CA9 Q16790 6/20 0.46
▸ ESR1 P03372 1/20 0.42
▸ CDC25A P30304 1/20 0.37
▸ CDC25C P30307 1/20 0.37
▸ GRM2 Q14416 1/20 0.37
▸ KCNA3 P22001 1/20 0.37
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ TDP1 Q9NUW8 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30228386 0.89 CA12 (0.45) CA12CA9ESR1CDC25ACDC25C
SCHEMBL20839408 0.82 CA12 (0.69) CA12CA9ESR1KMT2AALDH1A1
SCHEMBL30228096 0.82 CA12 (0.48) CA12CA9KCNA3MEN1KMT2A
SCHEMBL30228177 0.82 KDM4E (0.49) CA12CA9ESR1CDC25ACDC25C
SCHEMBL30227956 0.82 CA12 (0.48) CA12CA9ESR1CDC25ACDC25C
SCHEMBL30228226 0.82 CA12 (0.69) CA12CA9ESR1KMT2AALDH1A1
SCHEMBL4077626 0.81 CA12 (0.48) CA12CA9MEN1KMT2AKDM4E
SCHEMBL31089799 0.80 CA12 (0.51) CA12CA9GRM2KCNA3ALDH1A1
SCHEMBL30227943 0.79 CA12 (0.45) CA12CA9ESR1GRM2KCNA3
SCHEMBL30228052 0.79 CA12 (0.48) CA12CA9ESR1GRM2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023034346-A1 CHROMEN-2-ONE MODULATORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2023-03-09 — — WO disclosed
Send feedback